ViralFP

ViralFP provides a centralized database and analysis tools to catalog viral fusion proteins and predict fusion peptide locations in enveloped viruses such as Coronaviruses, Dengue, HIV, and Influenza.


Key Features:

  • Centralized Database: Contains curated information on viral fusion proteins and fusion peptides across enveloped viruses including Coronaviruses, Dengue, HIV, and Influenza.
  • Clustal Sequence Alignment: Performs sequence alignments of fusion protein sequences using Clustal for comparative analysis.
  • Weblogo Visualization: Generates sequence logos to visualize consensus sequences and motifs within fusion proteins using Weblogo.
  • Machine Learning-Based Prediction: Uses machine learning algorithms to predict the location of fusion peptides within fusion protein sequences, identifying regions that insert into host cell membranes.

Scientific Applications:

  • Viral Infection Mechanism Research: Elucidates mechanisms of membrane fusion and viral entry mediated by fusion proteins in enveloped viruses such as Coronaviruses, Dengue, HIV, and Influenza.
  • Immune Response Studies: Supports characterization of fusion proteins and fusion peptides as targets of immune recognition and antibody responses.
  • Therapeutic Target Identification: Facilitates identification of candidate fusion-peptide regions for antiviral drug or vaccine target selection.

Methodology:

Sequence alignment with Clustal, motif visualization with Weblogo, and predictive modeling using machine learning algorithms.

Topics

Details

Cost:
Free of charge
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Added:
6/8/2022
Last Updated:
6/8/2022

Operations

Publications

Moreira P, Sequeira AM, Pereira S, Rodrigues R, Rocha M, Lousa D. ViralFP: A Web Application of Viral Fusion Proteins. Frontiers in Medical Technology. 2021;3. doi:10.3389/fmedt.2021.722392. PMID:35047951. PMCID:PMC8757699.

PMID: 35047951
PMCID: PMC8757699
Funding: - Fundação para a Ciência e a Tecnologia: LISBOA-01-0145-FEDER-007660, PTDC/CCI269BIO/28200/2017